Mickaël Montembault

Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD

Anthony Cahn, J. Hamblin, Malcolm Begg et al. · Pulmonary Pharmacology & Therapeutics · 2017 · 68 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Investigate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Repeat Doses of Inhaled Nemiralisib in Adults with Persistent, Uncontrolled Asthma

Sanjeev Khindri, Anthony Cahn, Malcolm Begg et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Leveraging the Advantages Offered by Microfluidics to Enhance the Drug Discovery Process

Stephanie Y. F. Wong Hawkes, Maria J. V. Chapela, Mickaël Montembault · QSAR & Combinatorial Science · 2005 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Biomems +16

Synthesis of 4′-C, 3′-O bicyclic thymidine analogues using ring closure metathesis

Mickaël Montembault, Nathalie Bourgougnon, Jacques Lebreton · Tetrahedron Letters · 2002 · 28 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

Relationship between Pharmacokinetics and Pharmacodynamic Responses in Healthy Smokers Informs a Once-Daily Dosing Regimen for Nemiralisib

Malcolm Begg, Robert C. Wilson, J. Hamblin et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15